 |
 |
pl send me copy on retinal issues as want to include in upcoming seminar thanks haroon www.parkinsons.org.pk On Thu, Aug 20, 2009 at 9:29 PM, Ansa Ojanlatva <[log in to unmask]> wrote: > Hi, > there was a mention of research re:retina and dopamine not so long ago. > > Would someone have the message still available? Please send it to me again. > Someone is interested in facilitating discussion about the matter with > medical researchers and would like to have it as background. > Thank you. > > > Ansa Ojanlatva, PhD, CHES (ret.) > Docent, Health and Sexuality Education > > Authorized Sexuality Educator and Sexual Health Promotor (NACS), > Authorized in Sexual Science (NACS) > > Sanitas 3rd floor > Lemminkäisenkatu 1 > 20014 University of Turku, Finland > > mobile +358-400-823 816 > tel +358-2-333 8515 > fax +358-2-333 8439 > > Please use the mobile phone number for calling. > > > ----- Original Message ----- > From: rayilynlee <[log in to unmask]> > Date: Thursday, August 20, 2009 9:04 am > Subject: Loss of sex drive in PD > To: [log in to unmask] > > > > from Viartis > > > > 19th August 2009 - New research > > THE LOSS OF SEX DRIVE IN PARKINSON'S DISEASE > > The journal of sexual medicine [2009] 6 (4) : 1024-1031 (Kummer A, > > Cardoso > > F, Teixeira AL) Complete abstract > > > > Sexual dysfunction is a frequent but neglected problem in Parkinson's > > > > Disease, as muscular problems are usually seen as the characteristic > > symptoms. However, nearly two thirds (65.6%) of people with > > Parkinson's > > Disease have been found to suffer a loss of sex drive. Over 42% of > > those men > > with Parkinson's Disease also complained of erectile dysfunction. > > Ageing, > > female gender, lower education, and depression were most associated > > with > > decreased sexual desire. Decreased interest in sex was not associated > > with > > antidepressants. The neurological features that were most associated > > with a > > greater loss of sex drive were predominance of motor symptoms on the > > left > > side of the body, autonomic dysfunction, and severer Parkinson's > > Disease. In > > order to refer to this article on its own click here. > > > > 16th August 2009 - New report > > A FUTURE REPLACEMENT FOR SINEMET > > According to a new report, Depomed are developing a new drug called > > DM-1992 > > that could outperform Sinemet in the treatment of Parkinson's Disease. > > For > > their report click here. The details are on page 20. Just like > > Sinemet, > > DM-1992 is a combination of L-dopa and carbidopa, which prevents the > > breakdown of L-dopa. DM-1992 also includes AcuForm, which makes use > > of the > > properties of certain polymers. These polymers have long been used to > > > > "fluff" ice cream and are safe to use. For more information go to > > Depomed. > > Upon entering the stomach an AcuForm coated pill expands and is > > retained in > > the stomach for up to 8 hours. This helps to deliver a drug like > > Sinemet > > over a longer period of time. Depomed's formulation was able to extend > > the > > therapeutic duration of L-dopa to nine hours, compared to Sinemet CR's > > seven > > hours. The time to reach peak blood levels was extended to four hours > > > > compared to 2 hours for Sinemet CR. These advantages could enable a > > decrease > > in the dosage of L-dopa, and the ridding of side effects such as > > nausea and > > dyskinesia. In order to refer to this article on its own click here. > > > > Rayilyn Brown > > Director AZNPF > > Arizona Chapter National Parkinson Foundation > > [log in to unmask] > > > > ---------------------------------------------------------------------- > > To sign-off Parkinsn send a message to: mailto: > [log in to unmask] > > In the body of the message put: signoff parkinsn > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto: > [log in to unmask] > In the body of the message put: signoff parkinsn > -- Haroon Basheer ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn